{
  "version": "1.0",
  "priority_threshold": 0.6,
  "keywords": [
    "21 CFR Part 11", "Annex 11", "ALCOA+", "CSV", "CSA",
    "process validation", "cleaning validation", "equipment qualification",
    "deviation", "CAPA", "audit trail", "eTMF", "PSUR", "PBRER",
    "QMS", "LIMS", "MES", "eQMS", "ELN", "GxP cloud",
    "warning letter", "483", "inspection", "GMP", "GCP", "GLP", "GVP"
  ],
  "auto_assign": {
    "regulatory": "CCO",
    "competitive": "CRO", 
    "market": "CEO",
    "technology": "COO"
  },
  "boosts": {
    "severity_terms": { 
      "warning letter": 0.4, 
      "483": 0.35, 
      "guidance": 0.25, 
      "Part 11": 0.2, 
      "Annex 11": 0.2,
      "inspection": 0.3,
      "CAPA": 0.15,
      "deviation": 0.15
    },
    "domains": { 
      "fda.gov": 0.5, 
      "ema.europa.eu": 0.4, 
      "gov.uk": 0.3, 
      "canada.ca": 0.25
    }
  },
  "feeds": [
    "https://www.biospace.com/rss/",
    "https://www.bioworld.com/rss.xml",
    "https://www.fiercepharma.com/rss/xml",
    "https://www.fiercebiotech.com/rss/xml"
  ]
}